Literature DB >> 10860936

Elevation of intracellular cAMP inhibits growth factor-mediated matrix metalloproteinase-9 induction and keratinocyte migration.

L J McCawley1, S Li, M Benavidez, J Halbleib, E V Wattenberg, L G Hudson.   

Abstract

Receptor tyrosine kinases are regulators of diverse cellular functions including cell growth, cell survival, differentiation, locomotion, and morphogenesis. Activation of the cAMP-dependent protein kinase A inhibits receptor tyrosine kinase-stimulated growth responses in a number of cell types. In this study, we investigated the consequences of elevated cAMP on growth factor-mediated keratinocyte migration and matrix metalloproteinase (MMP)-9 induction in a human keratinocyte cell line. We found that elevation of intracellular cAMP by forskolin abolishes epidermal growth factor (EGF)- or scatter factor/hepatocyte growth factor-dependent colony dispersion. Concentrations of forskolin that inhibit growth factor-induced motility also eliminate EGF- or scatter factor/hepatocyte growth factor-dependent induction of the 92-kDa gelatinase/MMP-9. In contrast to findings obtained in fibroblasts, elevated intracellular cAMP did not interfere with growth factor-dependent activation of the p42/44 extracellular signal-regulated kinases, indicating that cAMP-dependent inhibition of migration and MMP-9 induction does not occur through perturbation of the extracellular signal-regulated kinases/mitogen-activated protein kinase pathway. However, forskolin effectively inhibited EGF-dependent activation of c-Jun N-terminal kinase and p38, demonstrating that cAMP selectively interferes with a different subset of growth factor-induced mitogen-activated protein kinase signaling cascades than reported previously in fibroblasts. These findings illustrate that EGF concurrently activates multiple mitogen-activated protein kinase signaling cascades in keratinocytes and suggests that each pathway contributes to maximal EGF-dependent migration and proteinase induction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10860936     DOI: 10.1124/mol.58.1.145

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  12 in total

1.  Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.

Authors:  Gouri Chatterjee; Andrea Rosner; Yi Han; Edward T Zelazny; Baolin Li; Robert D Cardiff; Archibald S Perkins
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases.

Authors:  A Rietz; Jp Spiers
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

3.  Occurrence of cGMP/nitric oxide-sensitive store-operated calcium entry in fibroblasts and its effect on matrix metalloproteinase secretion.

Authors:  Yong Huang; Min-Qiang Lu; Hua Li; Chi Xu; Shu-Hong Yi; Gui-Hua Chen
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

4.  Somatostatin inhibits cell migration and reduces cell counts of human keratinocytes and delays epidermal wound healing in an ex vivo wound model.

Authors:  Matthias Vockel; Simone Pollok; Ute Breitenbach; Ina Ridderbusch; Hans-Jürgen Kreienkamp; Johanna M Brandner
Journal:  PLoS One       Date:  2011-05-11       Impact factor: 3.240

5.  PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells.

Authors:  Karen D Cowden Dahl; Reema Zeineldin; Laurie G Hudson
Journal:  Mol Cancer Res       Date:  2007-05-02       Impact factor: 5.852

6.  Mechanical stretching modulates growth direction and MMP-9 release in human keratinocyte monolayer.

Authors:  Filippo Renò; Vincenzina Traina; Mario Cannas
Journal:  Cell Adh Migr       Date:  2009-07-01       Impact factor: 3.405

7.  Differential regulation of matrix metalloproteinase-9 and tissue plasminogen activator activity by the cyclic-AMP system in lipopolysaccharide-stimulated rat primary astrocytes.

Authors:  Soon Young Lee; Hee Jin Kim; Woo Jong Lee; So Hyun Joo; Se-Jin Jeon; Ji Woon Kim; Hee Sun Kim; Seol-Heui Han; Jongmin Lee; Seung Hwa Park; Jae Hoon Cheong; Won-Ki Kim; Kwang Ho Ko; Chan Young Shin
Journal:  Neurochem Res       Date:  2008-05-21       Impact factor: 3.996

8.  The putative tumor suppressor VILIP-1 counteracts epidermal growth factor-induced epidermal-mesenchymal transition in squamous carcinoma cells.

Authors:  Katharina Schönrath; Andres J Klein-Szanto; Karl H Braunewell
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

9.  Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration.

Authors:  Soni Pullamsetti; Stefanie Krick; Hüseyin Yilmaz; Hossein Ardeschir Ghofrani; Christian Schudt; Norbert Weissmann; Beate Fuchs; Werner Seeger; Friedrich Grimminger; Ralph Theo Schermuly
Journal:  Respir Res       Date:  2005-11-01

10.  Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.

Authors:  Ellena J Growcott; Karen G Spink; Xiaohui Ren; Saliha Afzal; Kathy H Banner; John Wharton
Journal:  Respir Res       Date:  2006-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.